Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estradiol/progesterone interaction in normal and pathologic breast cells.

P Mauvais-Jarvis, F Kuttenn, A Gompel

    Annals of the New York Academy of Sciences
    |January 1, 1986
    PubMed
    Summary

    Estradiol (E2) and progesterone (P) are crucial for female reproductive development. An imbalance, particularly unopposed estrogen, may promote breast cancer development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The importance of resident training in menopause.

    Women & health·2025
    Same author

    Lack of evidence that progesterone in ovulatory cycles causes breast cancer.

    Climacteric : the journal of the International Menopause Society·2023
    Same author

    Menopause hormone treatment after cancer.

    Climacteric : the journal of the International Menopause Society·2023
    Same author

    Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study.

    Gynecologic oncology·2021
    Same author

    Systemic lupus erythematosus and menopause.

    Climacteric : the journal of the International Menopause Society·2019
    Same author

    Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019

    Area of Science:

    • Reproductive Endocrinology
    • Hormonal Regulation of Cell Growth
    • Oncology

    Background:

    • Estradiol (E2) and progesterone (P) act synergistically for cell differentiation in the female genital tract.
    • E2 stimulates ductal growth, while P promotes lobular development in the breast.
    • Progesterone can antagonize estrogen by reducing estrogen receptor (ER) levels and increasing E2 metabolism.

    Purpose of the Study:

    • To investigate the antagonistic roles of E2 and P on breast cell multiplication.
    • To explore the potential link between luteal-phase defects and breast carcinogenesis.

    Main Methods:

    • Review of existing literature on E2 and P actions in target cells.
    • Analysis of data from cultured normal breast epithelial cells and fibroadenomas.
    • Examination of E2 and progestin effects on cell multiplication in vitro.

    Main Results:

    • E2 increases breast cell multiplication, partly via growth factor synthesis.
    • Progesterone and progestins exhibit an antagonistic effect on cell multiplication compared to E2.
    • Biochemical events of progesterone's anti-estrogen activity observed in endometrial and breast cells.

    Conclusions:

    • E2 and progestins act as antagonists regarding breast cell multiplication.
    • Prolonged luteal-phase defects leading to unopposed estrogen may promote breast carcinogenesis.

    Related Experiment Videos